Why Some Patients Undergoing Lipoprotein Apheresis Therapy Develop New Cardiovascular Events?

Why Some Patients Undergoing Lipoprotein Apheresis Therapy Develop New Cardiovascular Events?

Lipoprotein apheresis (LA) is an effective tool to reduce cardiovascular events (CVEs) in high-risk patients with elevations of low density lipoprotein-cholesterol (LDL-C) and/or Lipoprotein(a) (Lp(a)). All patients included into this retrospective analysis had experienced CVEs before the start of t...

Full description

Bibliographic Details
Main Authors: Ulrich Julius, Solveig Kuss, Sergey Tselmin, Ulrike Schatz, Stefan R. Bornstein
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
lipoprotein apheresis
cardiovascular events
LDL-cholesterol
LDL-cholesterol corrected for its content in Lipoprotein(a) particles
Lipoprotein(a)
targets for LDL-cholesterol
Online Access:https://www.mdpi.com/2308-3425/7/3/25

Internet

https://www.mdpi.com/2308-3425/7/3/25

Similar Items